Aigh Capital Management LLC Rezolute, Inc. Transaction History

Aigh Capital Management LLC

  • $247 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 10, 2022
SELL
$2.19 - $3.49 $159,688 - $254,480
-72,917 Reduced 86.0%
11,866 $33,000
Q2 2022

Aug 12, 2022
SELL
$2.6 - $3.85 $873,938 - $1.29 Million
-336,130 Reduced 79.86%
84,783 $274,000
Q1 2022

May 12, 2022
BUY
$2.27 - $5.1 $353,511 - $794,233
155,732 Added 58.73%
420,913 $1.42 Million
Q4 2021

Feb 10, 2022
BUY
$4.21 - $7.61 $1.12 Million - $2.02 Million
265,181 New
265,181 $1.27 Million

Others Institutions Holding RZLT

# of Institutions
62
Shares Held
38.5M
Call Options Held
1.6K
Put Options Held
24.6K
View Full List

About Rezolute, Inc.

RZLT Quotes by TradingView
  • Ticker RZLT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 38,827,600
  • Market Cap $172M
  • Description
  • Rezolute, Inc., a clinical stage biopharmaceutical company, develops transformative therapies for metabolic diseases associated with chronic glucose imbalance in the United States. The company's lead product candidate is RZ358, a human monoclonal antibody that is in Phase 2b clinical trial for the treatment of congenital hyperinsulinism, an ultr...
More about RZLT
Track This Portfolio

Track Aigh Capital Management LLC Portfolio

Follow Aigh Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Aigh Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Aigh Capital Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email